Respiratory Syncytial Virus Diagnostic Testing Market Segment Analysis – By Geography North America is the major region dominating the Respiratory Syncytial Virus Diagnostic Testing market with a market share of 42.16% in the year 2020. This can be attributed to the rising incidences of these infections and an increasing infant population over the forecast period 2021-2026. In order to produce companion diagnostics, increasing the number of strategic partnerships between pharmaceutical majors and in vitro diagnostic manufacturing companies are anticipated to make this a lucrative segment by signaling tremendous potential that could also be responsible for fueling the global RSV diagnostic testing market in the region.